Form 4: Oscar Health CFO Sells Shares Following Vesting of Restricted Stock Units
SEC Form 4
Oscar Health's Chief Financial Officer, Richard Scott Blackley, sold a portion of his Class A common stock after the vesting of restricted stock units.
Summary
- Richard Scott Blackley, the Chief Financial Officer of Oscar Health, Inc., has reported transactions involving the company's Class A common stock.
- On December 5, 2024, 62,500 restricted stock units vested, converting into Class A common stock.
- Following the vesting, Mr. Blackley sold 18,516 shares on December 6, 2024, at a weighted average price of $15.93 per share.
- He also sold another 11,423 shares on the same day at a weighted average price of $16.52 per share.
- After these transactions, Mr. Blackley beneficially owns 914,402 shares of Class A common stock.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of insider trading activity, which is neither positive nor negative in itself. The sales are related to tax obligations and are not indicative of a change in the company's outlook.
Risks
- Sales by company insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.
Industry Context
This is a routine disclosure of insider trading activity, which is common for publicly traded companies. It is typical for executives to sell shares to cover tax obligations when equity awards vest.
Comparison to Industry Standards
- Executive stock sales are a common occurrence in publicly traded companies, particularly after vesting periods for equity awards.
- Companies like UnitedHealth Group (UNH) and Humana (HUM) also see similar insider transactions, though the specific amounts and timing vary based on individual circumstances and company policies.
- The sale of shares by Oscar Health's CFO is within the normal range of insider activity observed in the healthcare industry.
Stakeholder Impact
- The stock sales may have a minor impact on the share price, but are unlikely to have a significant effect on other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 12/05/2024 | Restricted stock units vested, converting into Class A common stock. |
| 12/06/2024 | Shares were sold at weighted average prices of $15.93 and $16.52. |
| 12/09/2024 | Date of signature on the SEC Form 4. |
Keywords
Oscar Health, Richard Scott Blackley, insider trading, stock sale, restricted stock units, Class A common stock, SEC Form 4, equity awards, vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.